Financhill
Sell
34

NKE Quote, Financials, Valuation and Earnings

Last price:
$76.74
Seasonality move :
4.45%
Day range:
$75.74 - $78.41
52-week range:
$70.75 - $110.80
Dividend yield:
1.97%
P/E ratio:
23.69x
P/S ratio:
2.36x
P/B ratio:
8.14x
Volume:
13.9M
Avg. volume:
13.1M
1-year change:
-28.95%
Market cap:
$114.3B
Revenue:
$51.4B
EPS (TTM):
$3.24
Period Ending 2020-05-31 2021-05-31 2022-05-31 2023-05-31 2024-05-31
Revenue $37.4B $44.5B $46.7B $51.2B $51.4B
Revenue Growth (YoY) -4.38% 19.08% 4.88% 9.65% 0.28%
 
Cost of Revenues $21.2B $24.6B $25.2B $28.9B $28.5B
Gross Profit $16.2B $20B $21.5B $22.3B $22.9B
Gross Profit Margin 43.42% 44.82% 45.98% 43.53% 44.56%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $13.1B $13B $14.8B $16.4B $16.6B
Other Inc / (Exp) -$139M -$14M $181M $280M $228M
Operating Expenses $13.1B $13B $14.8B $16.4B $16.6B
Operating Income $3.1B $6.9B $6.7B $5.9B $6.3B
 
Net Interest Expenses $89M $262M $205M -- --
EBT. Incl. Unusual Items $2.9B $6.7B $6.7B $6.2B $6.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $348M $934M $605M $1.1B $1B
Net Income to Company $2.5B $5.7B $6B $5.1B $5.7B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $2.5B $5.7B $6B $5.1B $5.7B
 
Basic EPS (Cont. Ops) $1.63 $3.64 $3.83 $3.27 $3.76
Diluted EPS (Cont. Ops) $1.60 $3.56 $3.75 $3.23 $3.73
Weighted Average Basic Share $1.6B $1.6B $1.6B $1.6B $1.5B
Weighted Average Diluted Share $1.6B $1.6B $1.6B $1.6B $1.5B
 
EBITDA $4.2B $7.7B $7.5B $6.8B $7.2B
EBIT $3.1B $6.9B $6.7B $5.9B $6.3B
 
Revenue (Reported) $37.4B $44.5B $46.7B $51.2B $51.4B
Operating Income (Reported) $3.1B $6.9B $6.7B $5.9B $6.3B
Operating Income (Adjusted) $3.1B $6.9B $6.7B $5.9B $6.3B
Period Ending 2020-11-30 2021-11-30 2022-11-30 2023-11-30 2024-11-30
Revenue $11.2B $11.4B $13.3B $13.4B $12.4B
Revenue Growth (YoY) 8.88% 1.01% 17.24% 0.55% -7.72%
 
Cost of Revenues $6.4B $6.1B $7.6B $7.4B $7B
Gross Profit $4.8B $5.2B $5.7B $6B $5.4B
Gross Profit Margin 43.11% 45.9% 42.89% 44.6% 43.62%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.3B $3.8B $4.1B $4.1B $4B
Other Inc / (Exp) -$54M $102M $79M $75M $8M
Operating Expenses $3.3B $3.8B $4.1B $4.1B $4B
Operating Income $1.6B $1.5B $1.6B $1.8B $1.4B
 
Net Interest Expenses $70M $55M $16M -- --
EBT. Incl. Unusual Items $1.5B $1.5B $1.7B $1.9B $1.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $205M $164M $319M $344M $253M
Net Income to Company $1.3B $1.3B $1.3B $1.6B --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.3B $1.3B $1.3B $1.6B $1.2B
 
Basic EPS (Cont. Ops) $0.80 $0.84 $0.85 $1.04 $0.78
Diluted EPS (Cont. Ops) $0.78 $0.83 $0.85 $1.03 $0.78
Weighted Average Basic Share $1.6B $1.6B $1.6B $1.5B $1.5B
Weighted Average Diluted Share $1.6B $1.6B $1.6B $1.5B $1.5B
 
EBITDA $1.8B $1.6B $1.9B $2B $1.4B
EBIT $1.6B $1.5B $1.6B $1.8B $1.4B
 
Revenue (Reported) $11.2B $11.4B $13.3B $13.4B $12.4B
Operating Income (Reported) $1.6B $1.5B $1.6B $1.8B $1.4B
Operating Income (Adjusted) $1.6B $1.5B $1.6B $1.8B $1.4B
Period Ending 2020-11-30 2021-11-30 2022-11-30 2023-11-30 2024-11-30
Revenue $38.3B $46.3B $49.1B $51.5B $49B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $21.8B $25B $27.2B $28.9B $27.1B
Gross Profit $16.4B $21.3B $21.9B $22.7B $21.8B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $12.7B $14.1B $15.5B $16.6B $16.4B
Other Inc / (Exp) -$253M $167M $265M $140M $206M
Operating Expenses $12.7B $14.1B $15.5B $16.6B $16.4B
Operating Income $3.7B $7.2B $6.4B $6.1B $5.5B
 
Net Interest Expenses $197M $239M $122M -- --
EBT. Incl. Unusual Items $3.2B $7.1B $6.5B $6.3B $5.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $422M $928M $888M $994M $967M
Net Income to Company $2.8B $6.2B $5.6B $5.3B --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $2.8B $6.2B $5.6B $5.3B $4.9B
 
Basic EPS (Cont. Ops) $1.80 $3.90 $3.58 $3.46 $3.24
Diluted EPS (Cont. Ops) $1.75 $3.82 $3.55 $3.42 $3.24
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $4.9B $7.9B $7.3B $6.8B $6.1B
EBIT $3.7B $7.2B $6.4B $6.1B $5.5B
 
Revenue (Reported) $38.3B $46.3B $49.1B $51.5B $49B
Operating Income (Reported) $3.7B $7.2B $6.4B $6.1B $5.5B
Operating Income (Adjusted) $3.7B $7.2B $6.4B $6.1B $5.5B
Period Ending 2020-11-30 2021-11-30 2022-11-30 2023-11-30 2024-11-30
Revenue $21.8B $23.6B $26B $26.3B $23.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $12.2B $12.7B $14.7B $14.6B $13.3B
Gross Profit $9.6B $10.9B $11.3B $11.7B $10.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $6.2B $7.3B $8B $8.3B $8.1B
Other Inc / (Exp) -$40M $141M $225M $85M $63M
Operating Expenses $6.2B $7.3B $8B $8.3B $8.1B
Operating Income $3.3B $3.6B $3.3B $3.4B $2.6B
 
Net Interest Expenses $135M $112M $29M -- --
EBT. Incl. Unusual Items $3.2B $3.6B $3.5B $3.6B $2.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $402M $396M $679M $542M $509M
Net Income to Company $2.8B $3.2B $2.8B $3B $1.1B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $2.8B $3.2B $2.8B $3B $2.2B
 
Basic EPS (Cont. Ops) $1.77 $2.02 $1.79 $1.99 $1.48
Diluted EPS (Cont. Ops) $1.73 $1.99 $1.78 $1.97 $1.48
Weighted Average Basic Share $3.1B $3.2B $3.1B $3B $3B
Weighted Average Diluted Share $3.2B $3.2B $3.2B $3.1B $3B
 
EBITDA $3.8B $3.9B $3.8B $3.8B $2.8B
EBIT $3.3B $3.6B $3.3B $3.4B $2.6B
 
Revenue (Reported) $21.8B $23.6B $26B $26.3B $23.9B
Operating Income (Reported) $3.3B $3.6B $3.3B $3.4B $2.6B
Operating Income (Adjusted) $3.3B $3.6B $3.3B $3.4B $2.6B
Period Ending 2020-05-31 2021-05-31 2022-05-31 2023-05-31 2024-05-31
Cash and Equivalents $8.3B $9.9B $8.6B $7.4B $9.9B
Short Term Investments $439M $3.6B $4.4B $3.2B $1.7B
Accounts Receivable, Net $2.7B $4.5B $4.7B $4.1B $4.4B
Inventory $7.4B $6.9B $8.4B $8.5B $7.5B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.7B $1.5B $2.1B $1.9B $1.9B
Total Current Assets $20.6B $26.3B $28.2B $25.2B $25.4B
 
Property Plant And Equipment $8B $8B $7.7B $8B $7.7B
Long-Term Investments -- -- -- -- --
Goodwill $223M $242M $284M $281M $240M
Other Intangibles $274M $269M $286M $274M $259M
Other Long-Term Assets $2.3B $2.9B $3.8B $3.8B $4.5B
Total Assets $31.3B $37.7B $40.3B $37.5B $38.1B
 
Accounts Payable $2.2B $2.8B $3.4B $2.9B $2.9B
Accrued Expenses $2.4B $3.2B $2.5B $1.9B $2B
Current Portion Of Long-Term Debt $3M -- $500M -- $1B
Current Portion Of Capital Lease Obligations $445M $467M $420M $425M $477M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $8.3B $9.7B $10.7B $9.3B $10.6B
 
Long-Term Debt $9.4B $9.4B $8.9B $8.9B $7.9B
Capital Leases -- -- -- -- --
Total Liabilities $23.3B $25B $25B $23.5B $23.7B
 
Common Stock $3M $3M $3M $3M $3M
Other Common Equity Adj -$56M -$380M $318M $231M $53M
Common Equity $8.1B $12.8B $15.3B $14B $14.4B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $8.1B $12.8B $15.3B $14B $14.4B
 
Total Liabilities and Equity $31.3B $37.7B $40.3B $37.5B $38.1B
Cash and Short Terms $8.8B $13.5B $13B $10.7B $11.6B
Total Debt $9.7B $9.4B $9.4B $8.9B $8.9B
Period Ending 2020-11-30 2021-11-30 2022-11-30 2023-11-30 2024-11-30
Cash and Equivalents $8.6B $10.8B $6.5B $7.9B $8B
Short Term Investments $3.2B $4.4B $4.1B $2B $1.8B
Accounts Receivable, Net $3.7B $3.7B $5.4B $4.8B $5.3B
Inventory $6.1B $6.5B $9.3B $8B $8B
Prepaid Expenses -- -- -- -- --
Other Current Assets $2B $1.8B $2.1B $1.9B $1.9B
Total Current Assets $23.6B $27.2B $27.4B $24.6B $25B
 
Property Plant And Equipment $8B $7.8B $7.7B $8.1B $7.6B
Long-Term Investments -- -- -- -- --
Goodwill $223M $242M $281M $281M $240M
Other Intangibles $270M $265M $280M $269M $259M
Other Long-Term Assets $2.7B $3.4B $4B $3.9B $4.9B
Total Assets $34.8B $38.9B $39.6B $37.2B $38B
 
Accounts Payable $2.2B $2.8B $2.8B $2.7B $3.3B
Accrued Expenses $2.8B $2.5B $3.1B $1.6B $5.7B
Current Portion Of Long-Term Debt -- -- $500M -- $1B
Current Portion Of Capital Lease Obligations $458M $462M $426M $456M $481M
Other Current Liabilities $485M -- -- -- --
Total Current Liabilities $8.9B $8.9B $10.2B $9B $11.2B
 
Long-Term Debt $9.4B $9.4B $8.9B $8.9B $8B
Capital Leases -- -- -- -- --
Total Liabilities $24.2B $24B $24.4B $23.1B $23.9B
 
Common Stock $3M $3M $3M $3M --
Other Common Equity Adj -$429M $145M $559M $121M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $10.6B $14.9B $15.3B $14.1B $14B
 
Total Liabilities and Equity $34.8B $38.9B $39.6B $37.2B $38B
Cash and Short Terms $11.8B $15.1B $10.6B $9.9B $9.8B
Total Debt $9.5B $9.4B $9.4B $8.9B $9B
Period Ending 2020-05-31 2021-05-31 2022-05-31 2023-05-31 2024-05-31
Net Income to Stockholders $2.5B $5.7B $6B $5.1B $5.7B
Depreciation & Amoritzation $1.1B $797M $840M $859M $844M
Stock-Based Compensation $429M $611M $638M $755M $804M
Change in Accounts Receivable $1.2B -$1.6B -$504M $489M -$329M
Change in Inventories -$1.9B $507M -$1.7B -$133M $908M
Cash From Operations $2.5B $6.7B $5.2B $5.8B $7.4B
 
Capital Expenditures $1.1B $695M $758M $969M $812M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1B -$3.8B -$1.5B $564M $894M
 
Dividends Paid (Ex Special Dividend) -$1.5B -$1.6B -$1.8B -$2B -$2.2B
Special Dividend Paid
Long-Term Debt Issued $6.1B -- -- -- --
Long-Term Debt Repaid -$6M -$197M -- -$500M --
Repurchase of Common Stock -$3.1B -$608M -$4B -$5.5B -$4.3B
Other Financing Activities -$52M -$136M -$151M -$102M -$136M
Cash From Financing $2.5B -$1.5B -$4.8B -$7.4B -$5.9B
 
Beginning Cash (CF) $4.5B $8.3B $9.9B $8.6B $7.4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $3.9B $1.4B -$1.2B -$1B $2.4B
Ending Cash (CF) $8.3B $9.9B $8.6B $7.4B $9.9B
 
Levered Free Cash Flow $1.4B $6B $4.4B $4.9B $6.6B
Period Ending 2020-08-31 2021-08-31 2022-08-31 2023-08-31 2024-08-31
Net Income to Stockholders $1.5B $1.9B $1.5B $1.5B $1.1B
Depreciation & Amoritzation $217M $168M $160M $186M $184M
Stock-Based Compensation $136M $136M $170M $196M $183M
Change in Accounts Receivable -$990M $36M -$415M -$621M -$312M
Change in Inventories $689M $101M -$1.4B -$263M -$679M
Cash From Operations $882M $1.1B $357M -$66M $394M
 
Capital Expenditures $176M $184M $264M $253M $120M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$889M $501M -$214M $418M -$166M
 
Dividends Paid (Ex Special Dividend) -$384M -$435M -$480M -$524M -$558M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$113M -- -- -- --
Repurchase of Common Stock -- -$752M -$983M -$1.1B -$1.2B
Other Financing Activities -$53M -$42M -$22M -$41M -$17M
Cash From Financing -$248M -$743M -$1.4B -$1.6B -$1.6B
 
Beginning Cash (CF) $8.3B $9.9B $8.6B $7.4B $9.9B
Foreign Exchange Rate Adjustment $55M -$38M -$87M -$16M $19M
Additions / Reductions -$255M $869M -$1.3B -$1.2B -$1.4B
Ending Cash (CF) $8.1B $10.7B $7.2B $6.2B $8.5B
 
Levered Free Cash Flow $706M $927M $93M -$319M $274M
Period Ending 2020-11-30 2021-11-30 2022-11-30 2023-11-30 2024-11-30
Net Income to Stockholders $2.8B $6.2B $5.6B $5.3B --
Depreciation & Amoritzation $1.2B $694M $958M $750M --
Stock-Based Compensation $564M $592M $696M $793M $585M
Change in Accounts Receivable $886M -$142M -$1.9B $718M --
Change in Inventories $75M -$546M -$2.9B $1.3B --
Cash From Operations $4.5B $7.2B $2.7B $7.2B --
 
Capital Expenditures $908M $713M $896M $927M $474M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$3.1B -$2B -$442M $1.5B --
 
Dividends Paid (Ex Special Dividend) -$1.5B -$1.7B -$1.9B -$2.1B -$1.7B
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$213M -- -- -- --
Repurchase of Common Stock -$1.1B -$2.3B -$4.8B -$5.3B --
Other Financing Activities -$117M -$151M -$110M -$134M --
Cash From Financing $4.1B -$3B -$6.3B -$7.3B --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $5.5B $2.1B -$4.1B $1.4B --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $3.6B $6.5B $1.8B $6.3B --
Period Ending 2020-08-31 2021-08-31 2022-08-31 2023-08-31 2024-08-31
Net Income to Stockholders $1.5B $1.9B $1.5B $1.5B $1.1B
Depreciation & Amoritzation $217M $168M $160M $186M $184M
Stock-Based Compensation $136M $136M $170M $196M $183M
Change in Accounts Receivable -$990M $36M -$415M -$621M -$312M
Change in Inventories $689M $101M -$1.4B -$263M -$679M
Cash From Operations $882M $1.1B $357M -$66M $394M
 
Capital Expenditures $176M $184M $264M $253M $120M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$889M $501M -$214M $418M -$166M
 
Dividends Paid (Ex Special Dividend) -$384M -$435M -$480M -$524M -$558M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$113M -- -- -- --
Repurchase of Common Stock -- -$752M -$983M -$1.1B -$1.2B
Other Financing Activities -$53M -$42M -$22M -$41M -$17M
Cash From Financing -$248M -$743M -$1.4B -$1.6B -$1.6B
 
Beginning Cash (CF) $8.3B $9.9B $8.6B $7.4B $9.9B
Foreign Exchange Rate Adjustment $55M -$38M -$87M -$16M $19M
Additions / Reductions -$255M $869M -$1.3B -$1.2B -$1.4B
Ending Cash (CF) $8.1B $10.7B $7.2B $6.2B $8.5B
 
Levered Free Cash Flow $706M $927M $93M -$319M $274M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Sell
40
MSTR alert for Dec 24

MicroStrategy [MSTR] is down 8.7% over the past day.

Sell
26
NUTX alert for Dec 24

Nutex Health [NUTX] is up 9.77% over the past day.

Sell
48
VRNA alert for Dec 24

Verona Pharma PLC [VRNA] is up 7.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock